Cite
Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer.
MLA
Hirooka, Yoshiki, et al. “Prospective Multicenter Phase II Study of Gemcitabine plus Cisplatin in Patients with Unresectable Gallbladder Cancer.” Cancer Chemotherapy & Pharmacology, vol. 80, no. 1, July 2017, pp. 119–25. EBSCOhost, https://doi.org/10.1007/s00280-017-3341-6.
APA
Hirooka, Y., Ishikawa, T., Kawashima, H., Ohno, E., Nonogaki, K., Kanamori, A., Hirai, T., Uchida, H., Shirai, O., Ishikawa, H., & Goto, H. (2017). Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer. Cancer Chemotherapy & Pharmacology, 80(1), 119–125. https://doi.org/10.1007/s00280-017-3341-6
Chicago
Hirooka, Yoshiki, Takuya Ishikawa, Hiroki Kawashima, Eizaburo Ohno, Koji Nonogaki, Akira Kanamori, Takanori Hirai, et al. 2017. “Prospective Multicenter Phase II Study of Gemcitabine plus Cisplatin in Patients with Unresectable Gallbladder Cancer.” Cancer Chemotherapy & Pharmacology 80 (1): 119–25. doi:10.1007/s00280-017-3341-6.